SCHEMBL18901294

SCHEMBL18901294

CN(C)NCc1cccc(C(=O)NC[C@H]2CCCN2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 7/20 0.58
▸ ROCK1 Q13464 2/20 0.58
▸ PARP1 P09874 1/20 0.52
▸ IKBKB O14920 5/20 0.46
▸ MAPK10 P53779 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ SCN9A Q15858 1/20 0.42
▸ KDM1A O60341 1/20 0.42
▸ PKN2 Q16513 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CHUK O15111 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790228 0.88 ROCK2 (0.61) ROCK2ROCK1PARP1IKBKBMAPK10
SCHEMBL17788671 0.86 ROCK2 (0.59) ROCK2ROCK1PARP1IKBKBMAPK10
SCHEMBL10380819 0.85 ROCK2 (0.58) ROCK2ROCK1PARP1IKBKBMAPK10
SCHEMBL13766311 0.82 PARP1 (0.61) ROCK2ROCK1PARP1TSHRSMN1; SMN2
SCHEMBL279575 0.80 HPGD (0.59) ROCK2ROCK1PARP1SCN9AHPGD
SCHEMBL13060679 0.79 ROCK2 (0.54) ROCK2ROCK1PARP1IKBKBMAPK10
SCHEMBL5088410 0.77 ADRB1 (0.60) ROCK2ROCK1PARP1IKBKBSCN9A
SCHEMBL8274391 0.77 ADRB1 (0.60) ROCK2ROCK1PARP1IKBKBSCN9A
SCHEMBL31188482 0.77 ADRB1 (0.60) ROCK2ROCK1PARP1IKBKBSCN9A
SCHEMBL13005419 0.77 ROCK2 (0.52) ROCK2ROCK1PARP1IKBKBMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 — — EP disclosed
Send feedback